Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Sperikon

Tracked across 1 events · 6 articles · First seen Aug 04, 2026 · Last active Aug 10, 2026

Sentiment
60
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 60
Tech
On 4 August 2026, Singapore-based biotechnology company AuctuCel announced the launch of AuctuPrime, a next-generation chemically defined cell culture medium developed in collaboration with Sperikon. The product is designed to eliminate dependence on animal serum…
Impact: Sperikon collaborated with AuctuCel to develop AuctuPrime, contributing its expertise in regenerative medicine. This partnership enhances its involvement in advanced cell therapy manufacturing solutions.
Aug 04, 2026 · 6 articles
80 AuctuCel collaborated with SperikonAuctuCel launches...
ERGEN INTELLIGENCE
Track Sperikon live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.